Amprion is a global leader advancing precision medicine for neurodegenerative disorders through seed amplification testing.
Amprion’s SAAmplify™-ɑSYN (formerly SYNTap®) Biomarker Test is a first-in-class, qualitative Laboratory Developed Test (LDT) and the only seed amplification assay available to aid the diagnosis of synucleinopathies such as Parkinson’s disease (PD), Lewy body dementia (LBD/DLB), and Alzheimer’s disease (AD) with Lewy body variant.
Company Details
- Employees
- 38
- Founded
- 2007
- Address
- 149 New Montgomery St,
- in****@****nme.com
- Industry
- Biotechnology
- Website
- amprionme.com
- Keywords
- abeta, tau, neurology, healthcare, Early detection of Parkinson's Disease, Lewy body dementia, Alzheimer's disease, neurodegenerative disorders, alpha-synuclein, synucleinopathies, Lewy body copathology, seed amplification assay, SAA, precision brain diagnostics.
- HQ
- San Francisco, California
Amprion Questions
Amprion's website is amprionme.com
Amprion's LinkedIn profile is https://www.linkedin.com/company/amprion
Amprion has
38 employees.
View email and phone details for 38
employees at Amprion.
Amprion's industry is
Biotechnology
Amprion's top competitors are
Orsobio,
Candid Therapeutics,
Circle Pharma, Inc.,
858 Therapeutics,
Big Health,
Inflammatix, Inc.,
Mdisrupt,
Arsenal Biosciences, Inc.,
Pictorlabs Inc,
Amprion Gmbh.
Amprion's support email address is info@amprionme.com
Amprion's categories are Biotechnology
Amprion's founding year is 2007
